Birdwatch Archive

Birdwatch Note

2024-06-03 17:11:13 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Es un tratamiento en fase de estudio con un paciente. No es una cura ampliamente disponible. https://www.scmp.com/news/china/science/article/3263878/chinese-scientists-report-world-first-they-cure-patients-diabetes-cell-therapy Un tratamiento similar para la diabetes tipo I se encuentra disponible en Estados Unidos https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24610d9f-0c5a-4f55-93b3-d456300bfd5d La intencion de este post en el contexto de esta cuenta es claramente propaganda politica.

Written by 1C48EBC84C4A281BB7BD2FECFE5E824225FB0755CCF1D60DD212EAB41881A2F4
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1797292580863950910

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1797677432159584405
  • noteId - 1797677432159584405
  • participantId -
  • noteAuthorParticipantId - 1C48EBC84C4A281BB7BD2FECFE5E824225FB0755CCF1D60DD212EAB41881A2F4 Participant Details
  • createdAtMillis - 1717434673716
  • tweetId - 1797292580863950910
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Es un tratamiento en fase de estudio con un paciente. No es una cura ampliamente disponible. https://www.scmp.com/news/china/science/article/3263878/chinese-scientists-report-world-first-they-cure-patients-diabetes-cell-therapy Un tratamiento similar para la diabetes tipo I se encuentra disponible en Estados Unidos https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24610d9f-0c5a-4f55-93b3-d456300bfd5d La intencion de este post en el contexto de esta cuenta es claramente propaganda politica.

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2024-06-03 17:11:13 UTC
(1717434673716)
2024-06-04 03:57:21 UTC
(1717473441775)
CURRENTLY_RATED_HELPFUL 2024-06-05 20:45:56 UTC
(1717620356968)
CURRENTLY_RATED_HELPFUL 2024-06-04 03:57:21 UTC
(1717473441775)
CURRENTLY_RATED_HELPFUL

Note Ratings

rated at rated by
2024-06-04 06:49:10 -0500 Rating Details
2024-06-04 03:24:46 -0500 Rating Details
2024-06-04 01:54:02 -0500 Rating Details
2024-06-03 23:20:32 -0500 Rating Details
2024-06-03 22:41:23 -0500 Rating Details
2024-06-03 21:22:15 -0500 Rating Details
2024-06-03 20:06:47 -0500 Rating Details
2024-06-03 15:21:58 -0500 Rating Details
2024-06-03 14:49:50 -0500 Rating Details
2024-06-03 13:05:27 -0500 Rating Details
2024-06-06 01:51:24 -0500 Rating Details
2024-06-03 20:42:45 -0500 Rating Details
2024-06-03 20:01:26 -0500 Rating Details
2024-06-03 18:46:06 -0500 Rating Details
2024-06-03 18:17:49 -0500 Rating Details
2024-06-03 18:00:33 -0500 Rating Details
2024-06-03 17:50:41 -0500 Rating Details
2024-06-03 17:12:48 -0500 Rating Details
2024-06-03 16:43:03 -0500 Rating Details
2024-06-03 12:55:30 -0500 Rating Details
2024-06-03 12:12:13 -0500 Rating Details
2024-06-04 11:26:20 -0500 Rating Details
2024-06-04 10:30:42 -0500 Rating Details
2024-06-04 08:11:33 -0500 Rating Details
2024-06-04 02:43:10 -0500 Rating Details
2024-06-03 23:13:46 -0500 Rating Details
2024-06-03 22:59:10 -0500 Rating Details
2024-06-03 18:37:46 -0500 Rating Details
2024-06-03 15:02:30 -0500 Rating Details
2024-06-03 12:39:30 -0500 Rating Details